Recently, our company has reached a strategic cooperation with Boya united pharmaceutical institute CO.,LTD. on the Toutongding Syrup (100ml/bottle), to obtain the exclusive agency of the product.
MoreC&O reaches a strategic cooperation with Hailing Pharm of Changjiang Runfa Group on luliconazole cream
MoreNoscapine tablet is an over-the-counter drug (exclusive dosage form in China) manufactured by Qinghai Pharmaceutical Co., Ltd. for cough suppression, applied to dry cough. The drug has the advantages of fast onset of action, strong cough suppression
MoreRecently, we have received the Supplementary Drug Application Approval from the NMPA for Amoxicillin - Amoxicillin Capsules (0.25 g, 0.5 g) and Greats® - Irbesartan Tablets (75 mg). The products have passed the generic drug consistency evaluation, in
MoreShionogi completed the acquisition of Sumitomo Corporation’s 29% stake in C&O in December 2019. Upon completion of the acquisition, Shionogi became the sole shareholder with shareholding of 100% held in C&O.
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mail[email protected]
Official WeChat account Mobile page